Major Novartis shareholder calls for board shake-up after trial setbacks on September 13, 2026 activism Artisan Partners board shake-up David Samra drug trial setbacks executive compensation Giovanni Caforio M&A oversight Novartis shareholder +
Major Novartis shareholder calls for board shake-up after trial setbacks on September 12, 2026 acquisition activism Artisan Partners Avidity board shake-up clinical-trial setbacks corporate governance David Samra Giovanni Caforio M&A strategy Novartis shareholder +
Major Novartis shareholder calls for board shake-up after trial setbacks on September 11, 2026 acquisitions Artisan Partners Avidity board shake-up corporate governance David Samra drug-trial Giovanni Caforio MorphoSys Novartis setbacks +
Major Novartis shareholder calls for board shake-up after trial setbacks on September 11, 2026 acquisitions activism Artisan Partners board shake-up compensation reform David Samra Experimental drug Management procedure Novartis setbacks shareholder +
Mikael Dolsten Withdraws Candidacy for Novo Nordisk Board; Bavarian Nordic Chairman Resigns on November 14, 2025 Bavarian Nordic Board of Directors board shake-up chairman resignation Danish pharma Mikael Dolsten Nordisk personal reasons Withdraw (activity) +